Rapt Therapeutics Inc (NASDAQ:RAPT)

Delayed Data
As of Sep 22
 -1.07 / -5.84%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Rapt Therapeutics Inc have a median target of 40.00, with a high estimate of 48.00 and a low estimate of 31.00. The median estimate represents a +132.42% increase from the last price of 17.21.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Rapt Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.26%
Growthannually -22.76%


Growthquarterly --
Growthannually -100.00%
Key to the earnings and sales forecast charts.